{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:23:48Z","timestamp":1788269028958,"version":"build-2803163510"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>\n                                 <jats:sup>11<\/jats:sup>C-acetate (<jats:sup>11<\/jats:sup>C-ACE) uptake on PET\/CT was recently discovered to represent reactive astrocytes in the tumor microenvironment. This study aimed at evaluating the role of <jats:sup>11<\/jats:sup>C-ACE PET\/CT as an imaging biomarker of reactive astrogliosis in characterizing different types of gliomas.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this prospective study, a total of 182 patients underwent <jats:sup>11<\/jats:sup>C-ACE PET\/CT before surgery. The ratio of SUV<jats:sub>max<\/jats:sub> of a glioma to the SUV<jats:sub>mean<\/jats:sub> of the contralateral choroid plexus (<jats:sup>11<\/jats:sup>C-ACE TCR) on PET\/CT was calculated. <jats:sup>11<\/jats:sup>C-ACE TCRs were compared with the World Health Organization grades and isocitrate dehydrogenase 1 (<jats:italic toggle=\"yes\">IDH1<\/jats:italic>) mutation status. Grade 2 was considered low-grade tumor, and grades 3 and 4 were considered high-grade tumors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The median <jats:sup>11<\/jats:sup>C-ACE TCR was significantly higher in <jats:italic toggle=\"yes\">IDH1<\/jats:italic> wild-type (wt) tumors (n = 91) than in <jats:italic toggle=\"yes\">IDH1<\/jats:italic>-mutant (mt) tumors (n = 91) (2.38 vs 1.30, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). Of the 91 <jats:italic toggle=\"yes\">IDH1<\/jats:italic>-mt tumors, there were no differences in the median <jats:sup>11<\/jats:sup>C-ACE TCRs between oligodendrogliomas (ODs) and astrocytic tumors (1.40 vs 1.20, <jats:italic toggle=\"yes\">P<\/jats:italic> &gt; 0.05). In grading low- versus high-grade gliomas, the receiver operating characteristic curve analyses showed a higher area under the curve (0.951) in <jats:italic toggle=\"yes\">IDH1<\/jats:italic>-wt tumors than in <jats:italic toggle=\"yes\">IDH1<\/jats:italic>-mt tumors (0.783, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.002). Grade 2 ODs were well differentiated from high-grade gliomas. The <jats:sup>11<\/jats:sup>C-ACE TCR of grade 3 ODs was significantly lower than that of <jats:italic toggle=\"yes\">IDH1<\/jats:italic>-wt glioblastomas.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>High <jats:sup>11<\/jats:sup>C-ACE uptake is associated with high-grade <jats:italic toggle=\"yes\">IDH1<\/jats:italic>-wt tumors, thus facilitating differentiation from high-grade <jats:italic toggle=\"yes\">IDH1-mt<\/jats:italic> and low-grade gliomas. In particular, low <jats:sup>11<\/jats:sup>C-ACE uptake in ODs is advantageous in overcoming the limitation of radiolabeled amino acid tracers.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000004341","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T21:00:28Z","timestamp":1658523628000},"page":"863-868","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["11C-Acetate PET\/CT Detects Reactive Astrogliosis Helping Glioma Classification"],"prefix":"10.1097","volume":"47","author":[{"given":"Dongwoo","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joong Hyun","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Hyeon","family":"Yi","sequence":"additional","affiliation":[{"name":"Yonsei University College of Medicine, Seoul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae Young","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee-In","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misu","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Life Science, College of Life Science and Bioengineering, Incheon National University, Incheon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmin Mason","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Ho","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon Yoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngjoo","family":"Park","sequence":"additional","affiliation":[{"name":"Yonsei University College of Medicine, Seoul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Hyung","family":"Moon","sequence":"additional","affiliation":[{"name":"Neurosurgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Gu","family":"Kang","sequence":"additional","affiliation":[{"name":"Neurosurgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Hee","family":"Chang","sequence":"additional","affiliation":[{"name":"Neurosurgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Justin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Hoon","family":"Kim","sequence":"additional","affiliation":[{"name":"Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mijin","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,7,26]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","year":"2016","journal-title":"Acta Neuropathol"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/RLU.0000000000002006","article-title":"Prediction of overall survival based on isocitrate dehydrogenase 1 mutation and 18F-FDG uptake on PET\/CT in patients with cerebral gliomas","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1007\/s00259-019-04337-0","article-title":"Re-evaluation of the diagnostic performance of (11)C-methionine PET\/CT according to the 2016 WHO classification of cerebral gliomas","volume":"46","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrneurol.2017.44","article-title":"Advances in neuro-oncology imaging","volume":"13","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00259-012-2295-5","article-title":"Value of 11C-methionine PET in imaging brain tumors and metastases","volume":"40","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"e111598","DOI":"10.1371\/journal.pone.0111598","article-title":"11C-acetate PET imaging in patients with multiple sclerosis","volume":"9","year":"2014","journal-title":"PLoS One"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/0271678X20911469","article-title":"Astrocyte metabolism in multiple sclerosis investigated by 1-C-11 acetate PET","volume":"41","year":"2021","journal-title":"J Cereb Blood Flow Metab"},{"key":"bib8-20250621","article-title":"Visualization of reactive astrocytes in living brain of Alzheimer's disease patient","journal-title":"BioRxiv [preprint]"},{"key":"bib9-20250621","article-title":"Visualizing reactive astrogliosis extends survival in glioblastoma patients","journal-title":"BioRxiv [preprint]"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s13139-020-00672-5","article-title":"Choroid Plexus as the best reference region for standardized uptake value analysis on C11-acetate PET\/CT for grading and predicting prognosis in patients with cerebral gliomas","volume":"54","year":"2020","journal-title":"Nucl Med Mol Imaging"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s002590000472","article-title":"Carbon-11 acetate as a tracer of myocardial oxygen consumption","volume":"28","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.2967\/jnumed.109.062703","article-title":"The importance of acetyl coenzyme A synthetase for 11C-acetate uptake and cell survival in hepatocellular carcinoma","volume":"50","year":"2009","journal-title":"J Nucl Med"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s00259-005-0023-0","article-title":"PET imaging of brain astrocytoma with 1-11C-acetate","volume":"33","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib14-20250621","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.nucmedbio.2007.11.004","article-title":"Grading of brain glioma with 1-11C-acetate PET: comparison with 18F-FDG PET","volume":"35","year":"2008","journal-title":"Nucl Med Biol"},{"key":"bib15-20250621","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11307-008-0152-5","article-title":"11C-acetate PET in the evaluation of brain glioma: comparison with 11C-methionine and 18F-FDG-PET","volume":"10","year":"2008","journal-title":"Mol Imaging Biol"},{"key":"bib16-20250621","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1007\/s00259-018-3948-9","article-title":"The roles of (11)C-acetate PET\/CT in predicting tumor differentiation and survival in patients with cerebral glioma","volume":"45","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib17-20250621","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.3174\/ajnr.A1008","article-title":"Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography","volume":"29","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"key":"bib18-20250621","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s00259-015-2996-7","article-title":"Oligodendroglial component complicates the prediction of tumour grading with metabolic imaging","volume":"42","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib19-20250621","first-page":"1041","article-title":"Survival, prognostic factors, and volumetric analysis of extent of resection for anaplastic gliomas","volume":"52","year":"2020","journal-title":"Cancer Res Treat"},{"key":"bib20-20250621","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0303-8467(01)00197-4","article-title":"Immunohistochemical analysis of reactive astrocytes around glioblastoma: an immunohistochemical study of postmortem glioblastoma cases","volume":"104","year":"2002","journal-title":"Clin Neurol Neurosurg"},{"key":"bib21-20250621","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1523\/JNEUROSCI.23-10-04034.2003","article-title":"Exploitation of astrocytes by glioma cells to facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade","volume":"23","year":"2003","journal-title":"J Neurosci"},{"key":"bib22-20250621","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2202-12-9","article-title":"Non-invasive quantification of brain tumor\u2013induced astrogliosis","volume":"12","year":"2011","journal-title":"BMC Neurosci"},{"key":"bib23-20250621","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s13277-015-4242-0","article-title":"The role of astrocytes in the progression of brain cancer: complicating the picture of the tumor microenvironment","volume":"37","year":"2016","journal-title":"Tumor Biol"},{"key":"bib24-20250621","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/cancers11010005","article-title":"Glioblastoma: microenvironment and niche concept","volume":"11","year":"2018","journal-title":"Cancers (Basel)"},{"key":"bib25-20250621","doi-asserted-by":"crossref","first-page":"e1801076","DOI":"10.1002\/adhm.201801076","article-title":"Engineering controlled peritumoral inflammation to constrain brain tumor growth","volume":"8","year":"2019","journal-title":"Adv Healthc Mater"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004341","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:04:38Z","timestamp":1750536278000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,26]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004341","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,26]]}}}